What is it about?
Analysis of global costs of treatment of diabetes with different oral drugs.
Featured Image
Why is it important?
Because cost of treatment, and not the simple oh the drug, represent the real social burden.
Perspectives
Following this perspective, health decision makers can adopt different strategies and appreciate the economic value of the new drugs.
Torre Enrico
Read the Original
This page is a summary of: Cost-consequence analysis of sitagliptin versus sulfonylureas as add-on therapy for the treatment of diabetic patients in Italy, ClinicoEconomics and Outcomes Research, November 2017, Dove Medical Press,
DOI: 10.2147/ceor.s141477.
You can read the full text:
Contributors
The following have contributed to this page
